With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
This webinar highlights the continued importance of omnichannel engagement for healthcare practitioners and learners and the need to equip our internal teams appropriately.
MAPS speaks with Annemarie Clegg, CMO, OPEN Health, about the evolving role of Medical Affairs in providing context for payers, regulators and policy makers whose decisions can dramatically affect which patients can access industry innovations.
This webinar, a MAPS Middle East Chapter event, centers on experts discussing the evolving role of the MSL in the new normal.
In this interview recorded at MAPS 2022 Global with Lobna Salem we discuss building a Medical Affairs department from the ground up.
MAPS speaks with José Borbolla, Global Executive Medical Director at Esai, and Augusto Grinspan, VP Medical Affairs and Head LATAM with Merck KGaA about the evolution of Medical Affairs in Latin America.
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
One of the pandemic’s silver linings may well be gains in participation levels and the volume and quality of insights generated by eliminating the constraints of face-to-face interaction.
In this final article in the Leadership Perspectives series, John Pracyk interviews J&J leaders to explore a bold vision of career development that entails moving across sectors; namely, crossing over between Pharmaceuticals, Medical Devices, Vision, and Consumer Health.
In conversation with John Pracyk, MD, PhD, MBA, Medical Affairs leaders from Johnson & Johnson describe best practices to prepare our next generation of Chief Medical Officers.